The 2024 Health Industry Performance Exchange, held at the Four Seasons Hotel Grand Ballroom, was designed to encourage individuals and organizations that have contributed to the advancement of medical technology, the competitiveness of the medical industry, and the growth of the national economy through groundbreaking innovation and product development over the past year. The event was held in the following order: presentation of the Government Award for the Promotion of Healthcare Technology, presentation of the achievements of representative pharmaceutical companies and presentation of the achievements of representative innovative medical device companies.
Director Seungjun Na was selected as the final award recipient in October after the Public Review Committee deliberated on the KHIDI's recommendation. Na was recognized for enhancing the company's competitiveness in medical AI and strengthening its influence in the global medical market based on technological excellence by managing R&D projects for the Innovative Medical Device Company Technology Commercialisation Support Project. He is currently in charge of Core Line Soft's research asset team.
This award is recognition from the relevant ministries and professional organizations for the joint efforts of the relevant departments and the company as a whole this year,' said Na. We will continue to develop innovative technologies that contribute to the growth of the medical industry and strive to grow together with related industries.
Coreline Soft, meanwhile, is leading the development of AI-based medical imaging solutions and has the largest number of innovative integrated medical devices in Korea. It is also consolidating its position as a global leader in lung and thoracic diagnostics with its flagship product, AVIEW LCS Plus, which is revolutionizing lung cancer diagnosis and is conducting national lung cancer screening projects in five European countries, including Germany and Italy, as well as in South Korea.
